Corvus Pharmaceuticals is a clinical-stage, clinical science-driven biopharmaceutical company focused on developing novel therapies, including an approach centered on ITK inhibition, with investigational agents such as small molecules and antibodies in its pipeline.
Focus Areas
Notable Investments
